Aspire Biopharma secures up to $21M in convertible preferred stock financing
Source: SeekingAlpha
2026-02-11 07:51:20 ET
More on Aspire Biopharma Holdings, Inc.
- Seeking Alpha’s Quant Rating on Aspire Biopharma Holdings, Inc.
- Financial information for Aspire Biopharma Holdings, Inc.
Read the full article on Seeking Alpha
For further details see:
Aspire Biopharma secures up to $21M in convertible preferred stock financing
Aspire Biopharma Holdings Inc.
NASDAQ: ASBP
ASBP Trading
-4.1% G/L:
$1.17 Last:
25,766 Volume:
$1.22 Open:
ASBP Latest News
March 03, 2026 08:00:00 am
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
February 25, 2026 08:30:00 am
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
February 20, 2026 08:00:00 am
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 19, 2026 08:00:00 am
Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record
